Literature DB >> 4835074

Retroperitoneal fibrosis and ergot derivatives.

J F Stecker, H P Rawls, C J Devine, P C Devine.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4835074     DOI: 10.1016/s0022-5347(17)59635-4

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  7 in total

Review 1.  Chronic periaortitis--a new interpretation of Ormond's disease.

Authors:  B Martina
Journal:  Urol Res       Date:  1990

2.  Drug-induced localized systemic scleroses.

Authors:  J R Graham
Journal:  Trans Am Clin Climatol Assoc       Date:  1981

3.  Association of retroperitoneal fibrosis, proctitis and rectal stenosis.

Authors:  R Manna; E Caturelli; M G Pigini; M C Lanza-Tomasi; M A Pala; E Zupi
Journal:  Postgrad Med J       Date:  1981-10       Impact factor: 2.401

4.  Drugs associated with retroperitoneal fibrosis.

Authors:  R L Ristagno
Journal:  West J Med       Date:  1981-08

5.  Do beta-adrenoceptor blocking drugs cause retroperitoneal fibrosis?

Authors:  J P Pryor; W M Castle; D C Dukes; J C Smith; M E Watson; J L Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1983-09-03

6.  Retroperitoneal fibrosis after long-term daily use of ergotamine.

Authors:  L Damstrup; T T Jensen
Journal:  Int Urol Nephrol       Date:  1986       Impact factor: 2.370

7.  Retroperitoneal fibrosis and scleroderma.

Authors:  M A Mansell; R W Watts
Journal:  Postgrad Med J       Date:  1980-10       Impact factor: 2.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.